Acadia Healthcare (ACHC) to Release Earnings on Tuesday

Acadia Healthcare (NASDAQ:ACHC) will likely be issuing its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect Acadia Healthcare to post earnings of $0.33 per share and revenue of $844.1920 million for the quarter. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Investors may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, July 29, 2026 at 9:00 AM ET.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.40 EPS. On average, analysts expect Acadia Healthcare to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $34.51 on Friday. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $35.83. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The business has a 50 day moving average price of $27.64 and a 200-day moving average price of $23.18. The company has a market cap of $3.17 billion, a PE ratio of -2.82, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors have recently bought and sold shares of the company. EverSource Wealth Advisors LLC increased its position in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the last quarter. Wells Fargo & Company MN grew its stake in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after acquiring an additional 1,510 shares during the period. Prudential Financial Inc. raised its stake in Acadia Healthcare by 21.9% in the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after acquiring an additional 1,780 shares during the period. Glenmede Investment Management LP lifted its holdings in Acadia Healthcare by 15.6% during the third quarter. Glenmede Investment Management LP now owns 11,379 shares of the company’s stock valued at $282,000 after purchasing an additional 1,532 shares during the last quarter. Finally, iSAM Funds UK Ltd bought a new position in Acadia Healthcare during the third quarter worth about $296,000.

Analysts Set New Price Targets

Several equities analysts have weighed in on ACHC shares. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. KeyCorp upped their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Finally, Guggenheim upped their price objective on shares of Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $28.69.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.